Skip to main content
FinSpry Logo
FinSpry
AGIO logo
AGIO
(NASDAQ)
Agios Pharmaceuticals, Inc.
$35.20-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Agios Pharmaceuticals (AGIO) Stock Price & Financial Analysis

Agios Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$33.52 - $35.35
52-Week High$46.00
52-Week Low$22.24
Open$33.97
Volume1.43M
Average Volume (3M)1.43M
Market Cap2.04B
Shares Outstanding57.97M
Price to Sales (P/S)36.69
Price to Book (P/B)1.66
EV/EBITDA-4.14
Revenue (TTM)54.03M
Net Income (TTM)-412.78M
Free Cash Flow (TTM)-387.29M
EPS (TTM)$-7.07
Profit Margin-764.01%
Operating Margin-873.87%
Return on Equity (ROE)-34.60%
Debt to Equity0.03
50-Day MA$28.60
200-Day MA$33.78
52-Week Change24.78%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Agios Pharmaceuticals

What is the current stock price for AGIO?

As of the latest trading session, AGIO stock trades at $35.20. The 52-week range is $22.24–$46.00, with a day range of $33.52–$35.34.

What is the P/E ratio for AGIO?

The P/E ratio (Price-to-Earnings) for AGIO is shown in the Key Statistics section. This valuation metric helps compare Agios Pharmaceuticals, Inc. to industry peers.

Does AGIO pay dividends?

Agios Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for AGIO?

Based on 8 analysts, the consensus for AGIO is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of AGIO?

Agios Pharmaceuticals's market capitalization is $2.04B, classifying it as a mid-cap company. Agios Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.